T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy

被引:71
作者
Krackhardt, AM
Harig, S
Witzens, M
Broderick, R
Barrett, P
Gribben, JG
机构
[1] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA USA
关键词
D O I
10.1182/blood.V100.1.167
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic lymphocytic, leukemia (CLL) cells are ineffective antigen-presenting cells (APCs) although CD40-activated CLL cells can stimulate proliferation of autologous and allogeneic T cells. We examined the antigen-presenting capacity of CD40-, activated CLL cells as well as dendritic cells pulsed with apoptotic bodies of CLL cells to generate autologous and allogeneic immune responses against CLL cells. Both APC types were capable of generating T-cell lines that proliferate specifically in response to unstimulated CLL cells. Whereas cytotoxic responses against stimulated and unstimulated CLL cells could be repeatedly generated by allogeneic healthy donors, autologous cytotoxic immune responses against CD40-activated and native CLL cells were rarely detected. However, T cells isolated from patients with CLL could recognize and lyse allogeneic stimulated and unstimulated CLL cells, demonstrating that cytotoxic T cells from these tumor-bearing patients are functionally intact.
引用
收藏
页码:167 / 173
页数:7
相关论文
共 43 条
[1]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[2]   Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma [J].
Bendandi, M ;
Gocke, CD ;
Kobrin, CB ;
Benko, FA ;
Sternas, LA ;
Pennington, R ;
Watson, TM ;
Reynolds, CW ;
Gause, BL ;
Duffey, PL ;
Jaffe, ES ;
Creekmore, SP ;
Longo, DL ;
Kwak, LW .
NATURE MEDICINE, 1999, 5 (10) :1171-1177
[3]   The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes [J].
Bleul, CC ;
Wu, LJ ;
Hoxie, JA ;
Springer, TA ;
Mackay, CR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1925-1930
[4]  
BRUNNER KT, 1968, IMMUNOLOGY, V14, P181
[5]   CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: Stimulation of allogeneic versus autologous T cells generates different types of effector cells [J].
Buhmann, R ;
Nolte, A ;
Westhaus, D ;
Emmerich, B ;
Hallek, M .
BLOOD, 1999, 93 (06) :1992-2002
[6]   Acquired CD40-ligand deficiency in chronic lymphocytic leukemia [J].
Cantwell, M ;
Hua, T ;
Pappas, J ;
Kipps, TJ .
NATURE MEDICINE, 1997, 3 (09) :984-989
[7]   Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells [J].
Cerutti, A ;
Kim, EC ;
Shah, S ;
Schattner, EJ ;
Zan, H ;
Schaffer, A ;
Casali, P .
NATURE IMMUNOLOGY, 2001, 2 (02) :150-156
[8]  
Cheson B D, 1994, Curr Opin Hematol, V1, P268
[9]   FAILURE OF B-CELLS OF CHRONIC LYMPHOCYTIC-LEUKEMIA IN PRESENTING SOLUBLE AND ALLOANTIGENS [J].
DAZZI, F ;
DANDREA, E ;
BIASI, G ;
DESILVESTRO, G ;
GAIDANO, G ;
SCHENA, M ;
TISON, T ;
VIANELLO, F ;
GIROLAMI, A ;
CALIGARISCAPPIO, F .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 75 (01) :26-32
[10]  
Disis ML, 1996, J IMMUNOL, V156, P3151